Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Kang Sun

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Laboratory Hematology|February 26, 2022
Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemiaGuo-Kang Sun, Zi-Jun Xu, Fang-Yu Nan, et al.
Frontiers in Public Health|January 30, 2025
Development of a multi-laboratory integrated predictive model for silicosis utilizing machine learning: a retrospective case-control studyGuo-Kang Sun, Yun-Hui Xiang, Lu Wang, et al.
Cancer Medicine|July 6, 2021
Abnormal expression and methylation of PRR34-AS1 are associated with adverse outcomes in acute myeloid leukemiaFang-Yu Nan, Yu Gu, Zi-Jun Xu, et al.
Cancer Medicine|September 6, 2019
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemiaGuo-Kang Sun, Li-Juan Tang, Jing-Dong Zhou, et al.
Cancer Cell International|July 24, 2019
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabineLi-Juan Tang, Guo-Kang Sun, Ting-Juan Zhang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Laboratory Hematology|February 26, 2022
Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemiaGuo-Kang Sun, Zi-Jun Xu, Fang-Yu Nan, et al.
Frontiers in Public Health|January 30, 2025
Development of a multi-laboratory integrated predictive model for silicosis utilizing machine learning: a retrospective case-control studyGuo-Kang Sun, Yun-Hui Xiang, Lu Wang, et al.
Cancer Medicine|July 6, 2021
Abnormal expression and methylation of PRR34-AS1 are associated with adverse outcomes in acute myeloid leukemiaFang-Yu Nan, Yu Gu, Zi-Jun Xu, et al.
Cancer Medicine|September 6, 2019
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemiaGuo-Kang Sun, Li-Juan Tang, Jing-Dong Zhou, et al.
Cancer Cell International|July 24, 2019
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabineLi-Juan Tang, Guo-Kang Sun, Ting-Juan Zhang, et al.
Pageof 1